South Korea Mice Model Market (2025-2030)
The South Korea Mice Model Market was valued at $13.5 Million in 2025 and projected to reach to $20.9 Million by 2030, representing a compound annual growth rate of 9.1%. South Korea's mice model market is positioned for sustained growth driven by the country's advanced pharmaceutical and biotechnology ecosystem.
South Korea Mice Model Market Trends and Insights
- South Korea's robust pharmaceutical and biotechnology sector, combined with increasing investment in preclinical research infrastructure, is driving demand for laboratory mice models.
- South Korea's government support for life sciences research and the presence of leading academic institutions and contract research organizations (CROs) are accelerating market expansion. The mice model market in South Korea is benefiting from rising R&D expenditures in drug discovery and development, particularly in oncology, neurology, and immunology research.
- South Korea's emphasis on translational medicine and personalized healthcare is creating sustained demand for genetically modified and disease-specific mouse models.
- Between 2025 and 2030, South Korea is expected to see increased adoption of advanced breeding technologies and specialized mouse strains to support competitive pharmaceutical innovation..
Key Market Statistics
- CAGR (2025-2030) 9.1% CAGR
- Market Size, 2025 ~USD 13.5 Million
- Forecast, 2030 ~USD 20.9 Million
- Country South Korea
South Korea Mice Model Market Overview
Market Valuation Growth :
South Korea's mice model market is valued at USD 13.5 million in 2025 and is projected to reach USD 20.9 million by 2030, representing a robust 9.1% CAGR over the forecast period.
Pharmaceutical & Biotech Expansion :
South Korea's thriving pharmaceutical and biotechnology sector is a primary driver of mice model demand, with companies increasingly investing in preclinical research capabilities and drug development pipelines.
Government Research Investment :
South Korean government initiatives and funding programs support life sciences research infrastructure, creating favorable conditions for laboratory animal model adoption and preclinical research advancement.
Competitive CAGR Performance :
With a 9.1% CAGR, South Korea's mice model market demonstrates strong growth momentum, slightly below the global average of 10%, indicating steady regional market maturation and increasing research activity.
South Korea Mice Model Market Dynamics
- Increasing R&D investments by domestic and international companies, coupled with government support for life sciences research, are expanding demand for laboratory mice models in preclinical testing and drug development.
- The market benefits from South Korea's skilled workforce, modern research infrastructure, and regulatory frameworks that encourage innovation in pharmaceutical development. Looking ahead to 2030, the market is expected to grow steadily as South Korean biotech firms scale operations and pursue international collaborations.
- Rising prevalence of chronic diseases and increased focus on personalized medicine will further drive preclinical research activities.
- Additionally, growing adoption of advanced animal models and stricter regulatory requirements for drug safety testing will sustain demand for high-quality laboratory mice throughout the forecast period..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- South Korea's mice model market is valued at USD 13.5 million in 2025 and is forecast to reach USD 20.9 million by 2030.
- South Korea is experiencing a 9.1% CAGR, driven by strong pharmaceutical R&D investment and government support for life sciences.
- South Korea's demand for genetically modified and disease-specific mouse models is accelerating due to focus on translational medicine.
- South Korea's advanced breeding technologies and specialized mouse strains are becoming critical competitive advantages in drug discovery.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
South Korea Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : South Korean and international pharma firms need market intelligence to assess preclinical research capacity, identify local suppliers, and plan R&D investments in South Korea's growing drug development ecosystem.
- Biotechnology Firms : Biotech companies operating in or entering South Korea require detailed market data to benchmark their preclinical research activities, understand competitive positioning, and optimize laboratory animal model procurement strategies.
- Contract Research Organizations (CROs) : CROs providing preclinical testing services in South Korea need market insights to identify growth opportunities, understand client demand patterns, and develop service offerings aligned with regional pharmaceutical and biotech needs.
- Research Institutions & Universities : Academic and government research institutions in South Korea require market analysis to secure funding, justify research infrastructure investments, and understand trends in laboratory animal model utilization and regulatory requirements.
- Laboratory Animal Suppliers & Vendors : Suppliers of laboratory mice, breeding facilities, and related equipment need South Korea-specific market data to identify growth segments, understand customer requirements, and develop distribution and sales strategies in this expanding market.
Key Companies in the South Korea Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Size & Growth Projections : Access precise valuation data for South Korea's mice model market (USD 13.5M in 2025 to USD 20.9M in 2030) with detailed CAGR analysis to inform investment and expansion decisions in this high-growth regional market.
- Competitive Landscape Intelligence : Understand South Korea's unique pharmaceutical and biotechnology competitive dynamics, including key players, market consolidation trends, and opportunities for market entry or partnership development in the preclinical research sector.
- Government Policy & Regulatory Insights : Gain comprehensive understanding of South Korean government support mechanisms, R&D funding initiatives, and regulatory frameworks that shape the mice model market and create growth opportunities for suppliers and service providers.
- Demand Driver Analysis : Identify specific factors driving South Korea's 9.1% CAGR growth, including pharmaceutical company expansion, biotech innovation, research infrastructure development, and chronic disease prevalence trends unique to the Korean market.
- Strategic Market Positioning : Develop targeted go-to-market strategies for South Korea by understanding regional customer segments, research institution needs, pricing dynamics, and distribution channels specific to the Korean mice model ecosystem.
Frequently asked questions
What is the current size of South Korea's mice model market?
South Korea's mice model market is valued at USD 13.5 million in 2025.
What is the projected market size for South Korea by 2030?
South Korea's mice model market is projected to reach USD 20.9 million by 2030.
What is the CAGR for South Korea's mice model market?
South Korea's mice model market is growing at a CAGR of 9.1% from 2025 to 2030.
What factors are driving growth in South Korea's mice model market?
Growth in South Korea is driven by increased pharmaceutical R&D investment, government support for life sciences, rising demand for genetically modified models, and expansion of contract research organizations.
Which research areas are fueling demand for mice models in South Korea?
South Korea's demand is strongest in oncology, neurology, and immunology research, supported by the country's focus on translational medicine and personalized healthcare.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report